OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.920
+0.100 (5.49%)
Dec 5, 2025, 4:00 PM EST - Market closed
OS Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cost of Revenue | - | - | - | 0 | 1.16 | 4.25 |
| Gross Profit | - | - | - | -0 | -1.16 | -4.25 |
| Selling, General & Admin | 11.25 | 3.97 | 1.13 | 1.15 | 1.5 | 0.8 |
| Research & Development | 8.43 | 2.84 | 3.22 | 3.29 | 2.17 | 0.6 |
| Operating Expenses | 19.68 | 6.81 | 4.34 | 4.45 | 3.68 | 1.4 |
| Operating Income | -19.68 | -6.81 | -4.34 | -4.45 | -4.84 | -5.65 |
| Interest Expense | -0.01 | -2.05 | -3.45 | -1.81 | -2.58 | -0.46 |
| Interest & Investment Income | 0 | - | 0 | - | - | 0.06 |
| Other Non Operating Income (Expenses) | 1.41 | -0.02 | - | - | - | 0.02 |
| Pretax Income | -18.28 | -8.88 | -7.79 | -6.25 | -7.42 | -6.03 |
| Net Income | -18.28 | -8.88 | -7.79 | -6.25 | -7.42 | -6.03 |
| Preferred Dividends & Other Adjustments | 1.97 | 2 | 0.13 | 0.13 | 0.09 | - |
| Net Income to Common | -20.26 | -10.89 | -7.92 | -6.38 | -7.51 | -6.03 |
| Shares Outstanding (Basic) | 26 | 12 | 5 | 10 | 10 | 8 |
| Shares Outstanding (Diluted) | 26 | 12 | 5 | 10 | 10 | 8 |
| Shares Change (YoY) | 481.00% | 127.97% | -45.60% | - | 18.50% | - |
| EPS (Basic) | -0.78 | -0.88 | -1.46 | -0.64 | -0.75 | -0.72 |
| EPS (Diluted) | -0.78 | -0.88 | -1.46 | -0.64 | -0.75 | -0.72 |
| Free Cash Flow | -12.88 | -7.28 | -3.01 | -3.79 | -4.41 | -2.42 |
| Free Cash Flow Per Share | -0.50 | -0.59 | -0.55 | -0.38 | -0.44 | -0.29 |
| EBITDA | -19.44 | -6.81 | -4.34 | -4.45 | -4.84 | -5.65 |
| D&A For EBITDA | 0.24 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -19.68 | -6.81 | -4.34 | -4.45 | -4.84 | -5.65 |
Source: S&P Capital IQ. Standard template.
Financial Sources.